PHK
AZN icon

Point72 Hong Kong’s AstraZeneca AZN Stock Holding History

Point72 Hong Kong’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.35M Buy
8,795
+6,021
+217% +$911K 0.06% 188
2025
Q2 		$388K Buy
+2,774
New +$389K 0.03% 270
2024
Q3 		– Sell
-3,319
Closed -$518K – 468
2024
Q2 		$518K Buy
+3,319
New +$499K 0.03% 244

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Point72 Hong Kong's AZN Position: Q3 2025 in Review

Point72 Hong Kong increased its AstraZeneca (AZN) stake by 217% in Q3 2025, buying an estimated $911K and bringing the position to 8,795 shares worth $1.35M. The position accounts for 0.06% of the portfolio, ranked #188.

Point72 Hong Kong first reported a position in AZN in Q2 2024 and has held it in 3 quarters since. 1,288 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

  • Point72 Hong Kong held 8,795 shares of AstraZeneca worth $1.35M as of Q3 2025.
  • Point72 Hong Kong bought 6,021 AstraZeneca shares in Q3 2025, an estimated $911K.
  • AstraZeneca made up 0.06% of Point72 Hong Kong's portfolio in Q3 2025, its #188 holding.
  • Point72 Hong Kong first reported a position in AstraZeneca in Q2 2024 and has held it in 3 quarters since.
  • 1,288 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.